STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] Inventiva S.A. Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Inventiva S.A. (IVA) announced proxy logistics for its upcoming shareholder meeting. The company began mailing its Proxy Card and Voting Instructions to beneficial owners of its American Depositary Shares in connection with its Ordinary and Extraordinary General Meeting to be held on November 27, 2025 at 9 a.m. at Hôtel Villa M, 24-30 boulevard Pasteur, 75015 Paris, France.

The materials are furnished on a Form 6-K with exhibits: 99.1 (Proxy Card) and 99.2 (Voting Instructions).

Positive

  • None.

Negative

  • None.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of October 2025

 

Commission File Number: 001-39374

 

Inventiva S.A.

(Translation of registrant’s name into English)

 

50 rue de Dijon

21121 Daix France

+33 3 80 44 75 00
(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

x Form 20-F ¨ Form 40-F

 

 

 

 

 

 

INCORPORATION BY REFERENCE

 

The information contained in this report on Form 6-K, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

Proxy Card

 

On October 30, 2025, Inventiva S.A. (“Company”) began mailing its proxy card (“Proxy Card”) and Instructions for beneficial owners of American Depositary Shares (“Voting Instructions”) to the beneficial owners of the Company’s American Depositary Shares in connection with the Company’s Ordinary and Extraordinary General Meeting (“General Meeting”) that will be held on November 27, 2025 at 9 a.m., at Hôtel Villa M, 24-30, boulevard Pasteur – 75015 Paris, France. A copy of the Proxy Card is attached to this Report on Form 6-K as Exhibit 99.1 and a copy of the Voting Instructions as Exhibit 99.2.

 

 

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
99.1   Proxy Card.
99.2   Voting Instructions

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Inventiva S.A.
     
Date: October 30, 2025 By: /s/ Andrew Obenshain
    Name Andrew Obenshain
    Title: Chief Executive Officer

 

 

 

FAQ

What did Inventiva (IVA) announce in this Form 6-K?

Inventiva began mailing its Proxy Card and Voting Instructions to ADS beneficial owners for its upcoming General Meeting.

When and where is Inventiva’s General Meeting?

It will be held on November 27, 2025 at 9 a.m. at Hôtel Villa M, 24-30 boulevard Pasteur, 75015 Paris, France.

Who is receiving the proxy materials?

Beneficial owners of Inventiva’s American Depositary Shares are receiving the Proxy Card and Voting Instructions.

What exhibits are included with the filing?

Exhibit 99.1 is the Proxy Card and Exhibit 99.2 contains the Voting Instructions.

Does Inventiva file annual reports on Form 20-F or 40-F?

The company files annual reports under cover of Form 20-F.

Are the proxy materials deemed filed for liability purposes?

The materials are furnished and not deemed filed under Section 18 of the Exchange Act.
Inventiva S.A.

NASDAQ:IVA

IVA Rankings

IVA Latest News

IVA Latest SEC Filings

IVA Stock Data

771.71M
183.96M
5.16%
0.03%
Biotechnology
Healthcare
Link
France
Daix